Do caffeine and more selective adenosine A2A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson's disease?
Jiang‐Fan Chen, Michael A. Schwarzschild
Topics & Concepts
CaffeineNeuroprotectionAdenosineAdenosine receptorAdenosine A2A receptorParkinson's diseaseNeurodegenerationPharmacologyMedicineDopaminergicDiseaseReceptorDopamineInternal medicineAgonistAdenosine and Purinergic SignalingParkinson's Disease Mechanisms and TreatmentsOrganic Light-Emitting Diodes Research